is glp-1 a hoax Beyond Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management GLP-1 diabetes and weight-loss drug
Description
Characteristics of included studies We included a RCT and the post hoc analysis of it, three cohorts and a casecontrol pilot study

The mechanism is plausible (reward-pathway modulation) but unproven

We can provide personalized expectations

CrossRef Incretin-Based Therapy and Thyroid Cancer Risk: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Naseem Eisa, Omar Barood AACE Endocrinology and Diabetes.2026

Final pricing will be confirmed once its approved and available
